| Dr Kevin Anthony Marques, | |
|
200 E Chestnut St, Louisville, KY 40202-1831 | |
| (502) 629-8000 | |
| (303) 306-7753 |
| Full Name | Dr Kevin Anthony Marques |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 200 E Chestnut St, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013175603 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0420012378 (Vermont) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 47965 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Louisville Hospital | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
The Doctor of Nursing Practice (DNP) program at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been granted accreditation for a five-year term, the maximum number of years possible, by the Commission of Collegiate Nursing Education.
In a Lancet opinion piece, the journal's editor-in-chief Richard Horton writes about "[w]hy governments should take health more seriously," stating, "The purpose of government is to uphold the dignity of its people.
Virginia Attorney General Ken Cuccinelli says he is taking on the IRS over a Medicaid fraud settlement payment from which the state is owed $125 million.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
› Verified 9 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
The Doctor of Nursing Practice (DNP) program at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been granted accreditation for a five-year term, the maximum number of years possible, by the Commission of Collegiate Nursing Education.
In a Lancet opinion piece, the journal's editor-in-chief Richard Horton writes about "[w]hy governments should take health more seriously," stating, "The purpose of government is to uphold the dignity of its people.
Virginia Attorney General Ken Cuccinelli says he is taking on the IRS over a Medicaid fraud settlement payment from which the state is owed $125 million.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
› Verified 9 days ago
| Entity Name | Obhg Kentucky Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457644122 PECOS PAC ID: 5496910200 Enrollment ID: O20120628000666 |
News Archive
The Doctor of Nursing Practice (DNP) program at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been granted accreditation for a five-year term, the maximum number of years possible, by the Commission of Collegiate Nursing Education.
In a Lancet opinion piece, the journal's editor-in-chief Richard Horton writes about "[w]hy governments should take health more seriously," stating, "The purpose of government is to uphold the dignity of its people.
Virginia Attorney General Ken Cuccinelli says he is taking on the IRS over a Medicaid fraud settlement payment from which the state is owed $125 million.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Anthony Marques, Po Box 780982, Philadelphia, PA 19178-0982 Ph: (303) 306-7783 | Dr Kevin Anthony Marques, 200 E Chestnut St, Louisville, KY 40202-1831 Ph: (502) 629-8000 |
News Archive
The Doctor of Nursing Practice (DNP) program at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) has been granted accreditation for a five-year term, the maximum number of years possible, by the Commission of Collegiate Nursing Education.
In a Lancet opinion piece, the journal's editor-in-chief Richard Horton writes about "[w]hy governments should take health more seriously," stating, "The purpose of government is to uphold the dignity of its people.
Virginia Attorney General Ken Cuccinelli says he is taking on the IRS over a Medicaid fraud settlement payment from which the state is owed $125 million.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
› Verified 9 days ago
Lauren Simel Lewis, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3900 Kresge Way, Suite 30, Louisville, KY 40207 Phone: 502-891-8700 | |
Dr. Kara Beth Knapp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4123 Dutchmans Ln Ste 500, Louisville, KY 40207 Phone: 502-894-9494 Fax: 502-894-9404 | |
Dr. Catherine Renee Case, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4123 Dutchmans Ln Ste 500, Louisville, KY 40207 Phone: 502-894-9494 Fax: 502-894-9404 | |
Karen Duckwall, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2215 Portland Ave, Louisville, KY 40212 Phone: 502-774-8631 Fax: 502-776-8912 | |
Stanley A. Gall, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 550 S Jackson St, 3rd Floor, Louisville, KY 40202 Phone: 502-561-8850 Fax: 502-561-8851 | |
Dr. Sandra E Brooks, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3999 Dutchmans Ln, Suite 3c, Louisville, KY 40207 Phone: 502-899-6840 Fax: 502-899-6972 |